About me
Emily leads the Data Science & Analytics Trial Execution teams in R&D at AbbVie. Her teams’ focus is on enhancing the efficiency and quality of end-to-end trial execution through comprehensive data analysis and insights across RBQM, Feasibility & RWD, Medical & Safety, Trial Diversity and Business oversight needs and strategic advancements. Her teams have played a pivotal role in driving the transition from descriptive to predictive and prescriptive analytics and expanded the application of Machine Learning and AI in strategic decision making, trial design and operational execution of AbbVie’s clinical trials.
